An optimal experimental design for the development of preservative heart solutions

被引:9
作者
Ferrera, R
Michel, P
Hadour, G
Rodriguez, C
Ovize, M
Luu, RPT
机构
[1] INSERM, IFR Cardiovasc 39, F-69675 Bron, France
[2] HCL, Bron, France
[3] Univ Aix Marseille, Ctr St Jerome, Expt Res Methodol Lab, Marseille, France
关键词
D O I
10.1016/S1053-2498(01)00361-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of this study was to determine the optimal composition of a new medium for long-term hypothermic heart preservation. Methods: The independent effects of 19 compounds were evaluated using an in vitro porcine model. Tissue viability was assessed by measuring the reduction of methyltetrazolium salt, oxygen consumption and energetic compound levels on myocardial biopsies after 24-, 48- or 72-hour incubation periods. Screening of several compounds at two concentrations was performed to greatly reduce the number of experiments. Results: Pyruvate, aspartic acid, chlorpromazine and polyethylene glycol displayed protective properties, whereas calcium (2 mmol/liter), nifedipine, mannitol, magnesium (16 mmol/liter) and reduced glutathione showed deleterious effects. On the basis of these data, the composition of a new preservation solution (Group 1, n = 6) was compared with St Thomas solution (Group 11, n = 6) in an isolated, 24-hour pig heart preservation model. During reperfusion, left ventricular developed pressure and coronary blood flow were significantly higher (p < .01) in Group 1, suggesting better preservation. Conclusions: Our technique allows for rapid and efficient screening of many compounds currently used in the composition of preservation solutions for cardiac surgery.
引用
收藏
页码:260 / 270
页数:11
相关论文
共 13 条
[1]   Experimental design for a pharmaceutical formulation: optimisation and robustness [J].
Campisi, B ;
Chicco, D ;
Vojnovic, D ;
Phan-Tan-Luu, R .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (1-2) :57-65
[2]   IN-VITRO PRESERVATION OF CANINE HEARTS FOR 24 TO 28 HOURS FOLLOWED BY SUCCESSFUL ORTHOTOPIC TRANSPLANTATION [J].
COPELAND, JG ;
JONES, M ;
SPRAGG, R ;
STINSON, EB .
ANNALS OF SURGERY, 1973, 178 (06) :687-692
[3]   COMPARISON OF DIFFERENT TECHNIQUES OF HYPOTHERMIC PIG-HEART PRESERVATION [J].
FERRERA, R ;
LARESE, A ;
MARCSEK, P ;
GUIDOLLET, J ;
VERDYS, M ;
DITTMAR, A ;
DUREAU, G .
ANNALS OF THORACIC SURGERY, 1994, 57 (05) :1233-1239
[4]   Microperfusion techniques for long-term hypothermic preservation [J].
Ferrera, R ;
Michel, P ;
Hadour, G ;
Chiari, P ;
Chambers, D ;
Rodriguez, C .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (08) :792-800
[5]   QUANTITATIVE REDUCTION OF MTT BY HEARTS BIOPSIES IN-VITRO IS AN INDEX OF VIABILITY [J].
FERRERA, R ;
LARESE, A ;
BERTHOD, F ;
GUIDOLLET, J ;
RODRIGUEZ, C ;
DUREAU, G ;
DITTMAR, A .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1993, 25 (09) :1091-1099
[6]   Heart preservation for transplantation: Principles and strategies [J].
Jahania, MS ;
Sanchez, JA ;
Narayan, P ;
Lasley, RD ;
Mentzer, RM .
ANNALS OF THORACIC SURGERY, 1999, 68 (05) :1983-1987
[7]  
MACGOON DC, 1985, J THORAC CARDIOVASC, V89, P639
[8]  
MCGOON OC, 1980, J THORAC CARDIOVASC, V79, P150
[9]  
MICHEL P, IN PRESS COMP STUDY
[10]   ACUTE ORTHOTOPIC TRANSPLANTATION OF HEARTS STORED FOR 72 HOURS [J].
PROCTOR, E ;
MATTHEWS, G ;
ARCHIBALD, J .
THORAX, 1971, 26 (01) :99-+